Sector
PharmaceuticalsOpen
₹9.05Prev. Close
₹9.5Turnover(Lac.)
₹0.01Day's High
₹9.05Day's Low
₹9.0552 Week's High
₹052 Week's Low
₹0Book Value
₹77.79Face Value
₹10Mkt Cap (₹ Cr.)
30.83P/E
0.59EPS
13.49Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2014 | Dec-2012 | Dec-2011 | Dec-2010 |
|---|---|---|---|---|
Equity Capital | 34.07 | 34.07 | 54.07 | 34.07 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 504.56 | 513.29 | 611.03 | 665.17 |
Net Worth | 538.63 | 547.36 | 665.1 | 699.24 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Dec-2012 | Dec-2011 |
|---|---|---|
Revenue | 475.06 | 412 |
yoy growth (%) | 15.3 | |
Raw materials | -403.73 | -258.43 |
As % of sales | 84.98 | 62.72 |
Employee costs | -28.91 | -35.39 |
| Y/e 31 Mar( In .Cr) | Dec-2012 | Dec-2011 |
|---|---|---|
Profit before tax | -30.37 | 35.55 |
Depreciation | -8.3 | -8.23 |
Tax paid | -0.84 | -10.19 |
Working capital | 30.92 | |
Other operating items |
| Y/e 31 Mar | Dec-2012 | Dec-2011 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | 15.3 | |
Op profit growth | -119.9 | |
EBIT growth | -80.76 | |
Net profit growth | -79.03 |
| Particulars (Rupees in Crores.) | Mar-2015 | Mar-2014 | Dec-2013 | Dec-2012 | Dec-2011 |
|---|---|---|---|---|---|
Gross Sales | 757.93 | 2,059.8 | 1,746.78 | 1,631.54 | 1,557.04 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 757.93 | 2,059.8 | 1,746.78 | 1,631.54 | 1,557.04 |
Other Operating Income | 7.2 | 38.63 | 39.93 | 22.14 | 84.3 |
Other Income | 0 | 0 | 1.5 | 8.31 | 0.03 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Shashikant Patel
Additional Director
Pranav Koshal
Additional Director
Jignesh Jitendra Panchal
Additional Director
Milindkumar Laxmishankar Dixit
A B Road,
Manglia,
Madhya Pradesh - 453771
Tel: 91-731-2806271/2806275
Website: http://www.plethico.com
Email: [email protected]
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Summary
Plethico Pharmaceuticals Limited (PPL), an emerging global healthcare company was incorporated on 4th December 1991 as a private limited. PPL is engaged in the business of manufacturing, marketing and...
Read More
Reports by Plethico Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.